Table 2.
Mortality rate at 1 year post‐discharge
| Endpoints | Control group | Intervention group |
|---|---|---|
| SPPB | ||
| Adverse responders | 25.5 (95% CI 13.1, 37.9) | 62.5 (95% CI 19.2, 105.8)* |
| Non‐responders | 27.3 (95% CI 13.6, 41.0) | 23.1 (95% CI 0, 49.6) |
| Responders | 24.1 (95% CI 12.8, 35.5) | 18.0 (95% CI 11.2, 24.7) |
| GVT | ||
| Adverse responders | 36.8 (95% CI 13.0, 60.7)* | 0 |
| Non‐responders | 22.2 (95% CI 13.5, 31.0) | 27.9 (95% CI 16.3, 39.4) |
| Responders | 4.2 (95% CI 0, 12.8) | 13.6 (95% CI 5.1, 22.1) |
| Handgrip strength | ||
| Adverse responders | 33.3 (95% CI 21.4, 45.3) | 17.6 (95% CI 0, 37.9) |
| Non‐responders | 19.3 (95% CI 7.4, 27.7) | 17.5 (95% CI 5.2, 29.8) |
| Responders | 26.7 (95% CI 7.3, 39.4) | 22.3 (95% CI 13.8, 30.9) |
| MMSE | ||
| Adverse responders | 35.7 (95% CI 7.0, 64.4) | 0 |
| Non‐responders | 27 (95% CI 18.6, 35.4) | 20.2 (95% CI 11.5, 29.0) |
| Responders | 20 (95% CI 0.8, 39.2) | 19.7 (95% CI 9.4, 29.9) |
CI, confidence interval; GVT, Gait Velocity Test; MMSE, Mini‐Mental State Examination; SPPB, Short Physical Performance Battery.
Data are presented as % (95% CI).
*
P < 0.05.